Literature DB >> 2080414

[Pain-function indices for the follow-up of osteoarthritis of the hip and the knee].

M Lequesne1, M Samson, P Gérard, C Mery.   

Abstract

Algo-functional or severity index for hip diseases (AFIH), proposed in 1980 and validated in 1981, and algo-functional or severity index for knee diseases (AFIK), validated in 1985-1987, were applied to osteo-arthritis of the hip and of the knee. With strictly standardized interviews and well-trained investigators (20 to 30 patients), these indices are reliable: the interobserver reproducibility is good (mean discrepancy: 1/2 point) and the score usually decreases 3 points (mean) under active drug treatment. Each index was individually validated. The severity index for hip is more discriminant than that for knee diseases. The place of each index among the other assessment tests was appraised according to their discriminant capacity. These indices are useful: 1) for drug trials (analgesics and NSAIDs); 2) for the long term follow-up and the so-called chondroprotective agents trials; 3) for a rational decision concerning hip or knee prosthesis (score reaching 8 to 12 points). These AFIH and AFIK are well suited to daily practice and are not time-consuming: 3 to 4 minutes for each.

Entities:  

Mesh:

Year:  1990        PMID: 2080414

Source DB:  PubMed          Journal:  Rev Rhum Mal Osteoartic        ISSN: 0035-2659


  3 in total

1.  Primary osteoarthritis of hip, knee, and hand in relation to occupational exposure.

Authors:  M Rossignol; A Leclerc; F A Allaert; S Rozenberg; J P Valat; B Avouac; P Coste; E Litvak; P Hilliquin
Journal:  Occup Environ Med       Date:  2005-11       Impact factor: 4.402

2.  Comparative validation of the WOMAC osteoarthritis and Lequesne algofunctional indices in Greek patients with hip or knee osteoarthritis.

Authors:  Georgios A Konstantinidis; Vassilis H Aletras; Kleanthi-Akylina Kanakari; Konstantinos Natsis; Nicholas Bellamy; Dimitris Niakas
Journal:  Qual Life Res       Date:  2013-08-06       Impact factor: 4.147

3.  [Treatment of FAI via a minimally invasive ventral approach with arthroscopic assistance. Technique and midterm results].

Authors:  F Laude; E Sariali
Journal:  Orthopade       Date:  2009-05       Impact factor: 1.087

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.